Table 1.
Summary of 3 types of 5-ASA sustained-release oral formulations in Japan
Type of formulation | |||
---|---|---|---|
time-dependent | pH-dependent | MMX | |
Indication approved in Japan | UC (except severe), CD | UC (except severe) | UC (except severe) |
Regimen | TID, BID, OD | TID, OD | OD |
Maximum dose, mg/day | 4,000 | 3,600 | 4,800 |
Tablets | 250 mg, 500 mg | 400 mg | 1,200 mg |
Granules | 94% | None | None |